BACKGROUND: Dysnatremias are common and carry a risk of poor prognosis in acute subarachnoid hemorrhage (SAH) patients. The aim of this study was to determine the frequency and outcome of dysnatremias in 344 SAH patients treated by a targeted sodium management regimen. METHODS: We performed a 10-year observational dysnatremia study. Hyponatremia was defined as serum sodium (SNa) below 135 mmol/L, hypernatremia SNa above 150 mmol/L. RESULTS: Dysnatremia occurred in 35.8% patients; this was more frequently hyponatremia (19.8%) with a mean SNa 132.23±2.09 mmol/L, (16.0% mild, 3.2% moderate, 0.6% severe). Hypernatremia occurred less commonly in 11.9%, P<0.001 with a mean SNa 154.21±3.72 mmol/L, (6.1% mild, 2.9% moderate, 2.9% severe). In 4.8% of patients there were episodes of both dysnatremias. The incidence of hypo-osmolar hyponatremia was 6.4%, Cerebral salt wasting (CSW) 3.5%, syndrome of inappropriate secretion of antidiuretic hormone (SIADH) 0.3% and Central diabetes insipidus 1.7%. The hypernatremic patients had a higher inpatient mortality rate (P=0.001) and a worse overall outcome (P<0.001) than those hyponatremic or normotremic patients. Multivariate logistic regression showed that hypernatremia was an independent risk factor for increased inpatient mortality and poor outcome in patients with SAH. CONCLUSIONS: Our 10-year targeted sodium management regimen in acute SAH patients showed that dysnatremias were frequent, predominantly hyponatremia of which the more usual causes were CSW and not SIADH. Hypernatremia was shown to be an independent risk factor for inpatient mortality and poor outcome.

Department of Clinical Biochemistry Regional Hospital Liberec Czech Republic

Department of Neurosurgery Central Military Hospital Charles University Prague Czech Republic

Department of Neurosurgery Royal Hallamshire Hospital Sheffield UK

Neurocenter Neurointensive Care Unit Department of Neurosurgery Regional Hospital Liberec Czech Republic

000      

00000naa a2200000 a 4500

001      

bmc18011333

003      

CZ-PrNML

005      

20180420090705.0

007      

ta

008      

180404s2017 it f 000 0|eng||

009      

AR

024    7_

$a 10.23736/S0390-5616.16.03411-1 $2 doi

035    __

$a (PubMed)26496416

040    __

$a ABA008 $b cze $d ABA008 $e AACR2

041    0_

$a eng

044    __

$a it

100    1_

$a Spatenkova, Vera $u Neurocenter, Neurointensive Care Unit, Department of Neurosurgery, Regional Hospital, Liberec, Czech Republic - vera.spatenkova@nemlib.cz.

245    10

$a Dysnatremia as a poor prognostic indicator in patients with acute subarachnoid hemorrhage / $c V. Spatenkova, O. Bradac, P. de Lacy, P. Skrabalek, P. Suchomel,

520    9_

$a BACKGROUND: Dysnatremias are common and carry a risk of poor prognosis in acute subarachnoid hemorrhage (SAH) patients. The aim of this study was to determine the frequency and outcome of dysnatremias in 344 SAH patients treated by a targeted sodium management regimen. METHODS: We performed a 10-year observational dysnatremia study. Hyponatremia was defined as serum sodium (SNa) below 135 mmol/L, hypernatremia SNa above 150 mmol/L. RESULTS: Dysnatremia occurred in 35.8% patients; this was more frequently hyponatremia (19.8%) with a mean SNa 132.23±2.09 mmol/L, (16.0% mild, 3.2% moderate, 0.6% severe). Hypernatremia occurred less commonly in 11.9%, P<0.001 with a mean SNa 154.21±3.72 mmol/L, (6.1% mild, 2.9% moderate, 2.9% severe). In 4.8% of patients there were episodes of both dysnatremias. The incidence of hypo-osmolar hyponatremia was 6.4%, Cerebral salt wasting (CSW) 3.5%, syndrome of inappropriate secretion of antidiuretic hormone (SIADH) 0.3% and Central diabetes insipidus 1.7%. The hypernatremic patients had a higher inpatient mortality rate (P=0.001) and a worse overall outcome (P<0.001) than those hyponatremic or normotremic patients. Multivariate logistic regression showed that hypernatremia was an independent risk factor for increased inpatient mortality and poor outcome in patients with SAH. CONCLUSIONS: Our 10-year targeted sodium management regimen in acute SAH patients showed that dysnatremias were frequent, predominantly hyponatremia of which the more usual causes were CSW and not SIADH. Hypernatremia was shown to be an independent risk factor for inpatient mortality and poor outcome.

650    _2

$a akutní nemoc $7 D000208

650    _2

$a dospělí $7 D000328

650    _2

$a senioři $7 D000368

650    _2

$a péče o pacienty v kritickém stavu $x metody $7 D003422

650    _2

$a ženské pohlaví $7 D005260

650    _2

$a lidé $7 D006801

650    _2

$a hypernatremie $x krev $x epidemiologie $x terapie $7 D006955

650    _2

$a hyponatremie $x krev $x epidemiologie $x terapie $7 D007010

650    _2

$a mužské pohlaví $7 D008297

650    _2

$a lidé středního věku $7 D008875

650    12

$a hodnocení výsledků zdravotní péče $7 D017063

650    _2

$a prognóza $7 D011379

650    _2

$a subarachnoidální krvácení $x krev $x epidemiologie $x terapie $7 D013345

655    _2

$a časopisecké články $7 D016428

655    _2

$a pozorovací studie $7 D064888

700    1_

$a Bradac, Ondrej $u Department of Neurosurgery, Central Military Hospital, Charles University, Prague, Czech Republic.

700    1_

$a de Lacy, Patricia $u Department of Neurosurgery, Royal Hallamshire Hospital, Sheffield, UK.

700    1_

$a Skrabalek, Pavel $u Department of Clinical Biochemistry, Regional Hospital, Liberec, Czech Republic.

700    1_

$a Suchomel, Petr $u Neurocenter, Neurointensive Care Unit, Department of Neurosurgery, Regional Hospital, Liberec, Czech Republic.

773    0_

$w MED00008136 $t Journal of neurosurgical sciences $x 1827-1855 $g Roč. 61, č. 4 (2017), s. 371-379

856    41

$u https://pubmed.ncbi.nlm.nih.gov/26496416 $y Pubmed

910    __

$a ABA008 $b sig $c sign $y a $z 0

990    __

$a 20180404 $b ABA008

991    __

$a 20180420090808 $b ABA008

999    __

$a ok $b bmc $g 1288818 $s 1008145

BAS    __

$a 3

BAS    __

$a PreBMC

BMC    __

$a 2017 $b 61 $c 4 $d 371-379 $e 20151023 $i 1827-1855 $m Journal of neurosurgical sciences $n J Neurosurg Sci $x MED00008136

LZP    __

$a Pubmed-20180404